https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Heart-MS.jpg

Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Coronary Atherectomy Devices, Catheters (IVUS, OCT, Diagnostic, Balloon, Interventional), Guidewires (Diagnostic, Interventional), Introducer Sheaths, Vascular Closure, Balloon-Inflation, & CEP Devices

  • Year: 2021
  • Scope: 10 Years
  • Region: Global
  • Pages: 547
  • Type: MedSuite

In 2020, the global interventional cardiology market size was valued at approximately $11.1 billion, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market size is expected to reach an astonishing $16.2 billion in 2027.

Over 40% of the global interventional cardiology market share was controlled by Boston Scientific, Abbott, and Medtronic. This global market research includes an analysis of 46 interventional cardiology companies spawning across more than 70 countries in the world.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Interventional Cardiology Procedure Volumes
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Market Drivers & Limiters for Each Global Interventional Cardiology market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Global Interventional Cardiology market
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

COVID19 Impact on the Global Interventional Cardiology Market

Due to COVID19, the global interventional cardiology market size decreased by 20% from 2019, reaching a valuation of $11.1 billion in 2020. The global market is expected to recover in early 2022 and continue growing at a steady pace.

The World Health Organization confirmed COVID-19 as a pandemic in March 2020. Since then, millions of patients around the world had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and lung conditions. As a result, every region around the world has experienced record low numbers for angiographies and angioplasties in 2020.

For instance, in Spain, angioplasty procedures were down 40% within the first week of the lockdown in April. There were also 48% fewer diagnostic examinations and 81% fewer transcatheter procedure interventions. Lombardy, one of Italy’s worst affected regions, shut down 80% of its cardiac surgical units in order to preserve resources for emergency COVID-related cases.

Global Interventional Cardiology Market Insights

Global technologies, such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed.

Global Interventional Cardiology Market Size by Segment, 2017-2027

Access to healthcare and overall hospital infrastructure in developing countries within Latin America and the Asia Pacific, such as China and India, have been increasing over the last decade. In Brazil, for example, healthcare access in the most remote and poorest areas of the country has been dramatically improved through their Family Health Program (PSF) initiative. Since this program launched in 1994, states in Brazil were required to allocate a minimum of 12% of the total budget to health, while municipal governments must spend 15% of their budget on health.

Global Interventional Cardiology Market Share Insight

In 2020, the global interventional cardiology market share was controlled by three key competitors – Boston Scientific, Abbott, and Medtronic.

Global Interventional Cardiology Market Share Leaders, 2017-2027

Boston Scientific was the leading competitor in the global market for interventional cardiology devices in 2020. The company was the market leader in coronary balloon catheters, coronary embolic protection devices, and coronary atherectomy devices markets. Boston Scientific offers the Maverick™, Apex™, and Emerge® PTCA devices, as well as the Flextome™ cutting balloon catheter.

Abbott was the second leading competitor in the global interventional cardiology market. The company held notable positions in the interventional coronary guidewire, coronary stent, FFR guidewire (within the diagnostic coronary catheter and guidewire market), and OCT catheter markets.

Medtronic was the third leading competitor in the global market in 2020. The company performed the strongest in the interventional coronary catheter market, where it offered the Launcher®, Sherpa NX™ Active, and Sherpa NX™ Balanced product lines under its portfolio.

Report Regional Coverage

Throughout this research series, iData Research has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Detailed Market Segmentation

While this MedSuite report contains all the Global Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

  • Coronary Stent Market – MedCore – The market is further broken down into segments by:
    • Device Type: Bare-Metal Stents, and Drug-Eluting Stents.
  • Coronary Balloon Catheter Market – MedCore – The market is also further segmented by:
    • Device Type: PTCA Balloon, Specialty Balloon, and Drug-Eluting Balloon catheters.
  • Balloon-Inflation Device Market – MedCore – In-depth analysis of the Balloon-Inflation Device market.
  • Interventional Coronary Catheter Market – MedCore – The interventional catheters are used to place devices, such as stents and balloons, and are analyzed on a unit-basis within this global report.
  • Interventional Coronary Guidewire Market – MedCore – Interventional guidewires are often the first device type to cross an arterial lesion, and they are analyzed in-depth within this market research.
  • Coronary Embolic Protection Device Market – MedCore – The research includes an in-depth analysis of the Coronary Embolic Protection Device market.
  • Coronary Atherectomy Device Market – MedCore – This market report includes an in-depth analysis of the intricate Coronary Atherectomy devices market.
  • Introducer Sheath Market – MedCore – This market report includes an in-depth analysis of the Introducer Sheath market.
  • Coronary Vascular Closure Device (VCD)  Market – MedCore – Development of both the peripheral and coronary markets for minimally invasive cardiovascular therapies created a market for post-procedural vascular closure devices (VCDs).
  • Diagnostic Coronary Catheter & Guidewire Market – MedCore – The chapter takes a closer look at the different market segments, including Diagnostic Catheter, Diagnostic Guidewire, and Fractional Flow Reserve Guidewire markets.
  • Coronary Intravascular Ultrasound (IVUS) Market – MedCore – This global market research takes a closer look at the fast-growing Coronary IVUS device market.
  • Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE OF CONTENTS FOR THE GLOBAL INTERVENTIONAL CARDIOLOGY MARKET REPORT SUITE

TABLE OF CONTENTS ILIST OF FIGURES XIVLIST OF CHARTS XXVEXECUTIVE SUMMARY 1GLOBAL INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW 1COMPETITIVE ANALYSIS 4MARKET TRENDS 6MARKET DEVELOPMENTS 9PROCEDURE NUMBERS 11MARKETS INCLUDED 12VERSION HISTORY 13RESEARCH METHODOLOGY 14Step 1: Project Initiation & Team Selection 14Step 2: Prepare Data Systems and Perform Secondary Research 17Step 3: Preparation for Interviews & Questionnaire Design 19Step 4: Performing Primary Research 20Step 5: Research Analysis: Establishing Baseline Estimates 22Step 6: Market Forecast and Analysis 23Step 7: Identify Strategic Opportunities 25Step 8: Final Review and Market Release 26Step 9: Customer Feedback and Market Monitoring 27

IMPACT OF COVID-19 ON THE GLOBAL INTERVENTIONAL CARDIOLOGY DEVICE MARKET

2.1 INTRODUCTION 282.2 COUNTRY PROFILE 302.2.1 North America 302.2.2 Latin America 302.2.3 Western Europe 312.2.4 Central & Eastern Europe 312.2.5 Asia-Pacific 322.2.6 Middle East 322.2.7 Africa 332.3 ANALYSIS BY MARKET SEGMENT 342.3.1 Best Case Scenario 342.3.2 Base Case Scenario 352.3.3 Worst Case Scenario 36

DISEASE OVERVIEW

3.1 BASIC ANATOMY 383.2 DISEASE TREATMENTS AND DIAGNOSTICS 403.2.1 General Diagnostics 403.2.2 Coronary Artery Disease (CAD) 403.2.3 Myocardial Infarction (MI) 413.2.4 Angina Pectoris 423.3 PATIENT DEMOGRAPHICS 433.3.1 General Statistics 43

PRODUCT ASSESSMENT

4.1 INTRODUCTION 454.2 PRODUCT PORTFOLIOS 454.2.1 Coronary Stent Market 454.2.2 Coronary Balloon Catheter Market 484.2.3 Balloon-Inflation Device Market 514.2.4 Interventional Coronary Catheter Market 524.2.5 Interventional Coronary Guidewire Market 554.2.6 Coronary Embolic Protection Device Market 584.2.6.1 Saphenous Vein Grafts 584.2.6.2 Protection Mechanism 584.2.6.2.1 Filter Basket 584.2.6.2.2 Distal Balloon Occlusion 594.2.7 Coronary Atherectomy Device Market 604.2.7.1 Laser Atherectomy 604.2.7.2 Directional Coronary Atherectomy (DCA) 604.2.7.3 Mechanical Atherectomy 614.2.8 Coronary Thrombectomy Device Market 624.2.9 Coronary Chronic Total Occlusion Device Market 634.2.10 Coronary Introducer Sheath Market 654.2.10.1 Femoral Approach 654.2.10.2 Radial/Brachial Approach 664.2.11 Coronary Vascular Closure Device Market 684.2.12 Diagnostic Coronary Catheter & Guidewire 704.2.13 Coronary Intravascular Ultrasound Market 724.2.14 Optical Coherence Tomography Market 744.2.15 Hemostasis Valve Market 764.3 REGULATORY ISSUES AND RECALLS 774.3.1 Abbott 774.3.1.1 Coronary Stent 774.3.1.2 Coronary Balloon Catheter 774.3.1.3 Introducer Sheath 794.3.1.4 Coronary Vascular Closure Device 794.3.2 Boston Scientific 804.3.2.1 Coronary Stent 804.3.2.2 Coronary Balloon Catheter 804.3.2.3 Balloon-Inflation Device 814.3.2.4 Interventional Coronary Catheter 814.3.2.5 Interventional Coronary Guidewire 824.3.2.6 Coronary Thrombectomy 834.3.3 Cardinal Health 844.3.3.1 Coronary Stent 844.3.4 Medtronic 854.3.4.1 Coronary Stent 854.3.4.2 Introducer Sheath 854.3.4.3 Coronary Balloon Catheter 864.3.4.4 Interventional Coronary Catheter 864.3.5 Merit Medical Systems 884.3.5.1 Introducer Sheath 884.3.7 Terumo 894.3.7.1 Interventional Coronary Catheter 894.3.7.2 Introducer Sheath 904.3.7.3 Coronary Vascular Closure Device 914.4 CLINICAL TRIALS 924.4.1 Coronary Stent 934.4.1.1 Abbott 934.4.1.2 Boston Scientific 944.4.1.3 Medtronic 954.4.2 Coronary Balloon Catheter 994.4.2.1 Boston Scientific 994.4.2.2 Medtronic 994.4.3 Balloon Inflation Device 1004.4.3.1 Central Arkansas Veterans Healthcare System 1004.4.3.2 Guy’s and St Thomas’ NHS Foundation Trust 1004.4.4 Interventional Coronary Catheter 1014.4.4.1 Medtronic 1014.4.4.2 Philips 1034.4.5 Coronary Embolic Protection Device 1044.4.5.1 Icahan School of Medicine at Mount Sinai 1044.4.5.2 Javelin Medical 1044.4.5.3 Keystone Heart 1054.4.5.4 Microvention-Terumo, Inc 1064.4.6 Coronary Atherectomy Device 1074.4.6.1 Segeberger Kliniken GmbH 1074.4.6.2 Spectranetics Corporation 1074.4.7 Coronary Vascular Closure Device 1084.4.7.1 Cordis Corporation 1084.4.7.2 Medtronic 1094.4.7.3 Terumo Medical Corporation 1094.4.8 Coronary Intravascular Ultrasound 1104.4.8.1 Aarhhus University Hospital Skejby 1104.4.8.2 European Cardiovascular Research Institute 1114.4.9 Coronary Optical Coherence Tomography 1124.4.9.1 Columbia University 112

GLOBAL INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

5.1 INTRODUCTION 1135.1.1 Population at Risk 1135.2 MARKET OVERVIEW 1155.3 TREND ANALYSIS BY REGION 1205.4 DRIVERS AND LIMITERS 1235.4.1.1 Market Drivers 1235.4.1.2 Market Limiters 1255.5 COMPETITIVE MARKET SHARE ANALYSIS 1285.6 MERGERS AND ACQUISITIONS 1345.7 COMPANY PROFILES 1365.7.1 Abbott 1365.7.2 Asahi Intecc 1385.7.3 Boston Scientific 1395.7.4 Cardinal Health 1405.7.4.1 Cordis (Cardinal Health) 1415.7.5 Cardiovascular Systems Inc. 1425.7.6 Cook Medical 1435.7.7 Medtronic 1445.7.8 Merit Medical Systems 1465.7.9 Penumbra 1475.7.10 Philips 1485.7.11 Teleflex 1505.7.12 Terumo 1525.8 SWOT ANALYSIS 1545.8.1 Abbott 1555.8.2 Asahi Intecc 1565.8.3 Boston Scientific 1575.8.4 Cardinal Health 1585.8.5 Cardiovascular Systems Inc. 1595.8.6 Cook Medical 1605.8.7 Medtronic 1615.8.8 Merit Medical Systems 1625.8.9 Penumbra 1635.8.10 Philips 1645.8.11 Teleflex 1655.8.12 Terumo 166

PROCEDURE NUMBERS

6.1 INTRODUCTION 1676.2 PROCEDURES 1706.2.1.1 Angiography Procedures 1706.2.1.2 Angioplasty Procedures 1706.2.1.3 Coronary Atherectomy Procedures 1706.2.1.4 Catheterization Procedures 1716.2.2 Global Procedures 1726.2.3 North America Procedures 1746.2.4 Latin America Procedures 1766.2.5 Western Europe Procedures 1786.2.6 Central & Eastern Europe Procedures 1806.2.7 Middle East Procedures 1826.2.8 Asia-Pacific Procedures 1846.2.9 Africa Procedures 186

NORTH AMERICA MARKET

7.1 INTRODUCTION 1887.1.1 Population at Risk 1887.1.2 Countries Included 1897.2 MARKET OVERVIEW 1907.3 MARKET ANALYSIS AND FORECAST 1967.3.1 Coronary Stent Market 1967.3.1.1 Total Coronary Stent Market 1997.3.1.1.1 Bare-Metal Stent Market 2007.3.1.1.2 Drug-Eluting Stent Market 2017.3.2 Coronary Balloon Catheter Market 2027.3.2.1 Total Coronary Balloon Catheter Market 2047.3.2.1.1 PTCA Balloon Catheter Market 2057.3.2.1.2 Drug-Eluting Balloon Catheter Market 2067.3.2.1.3 Specialty Balloon Catheter Market 2077.3.3 Balloon-Inflation Device Market 2087.3.4 Interventional Coronary Catheter Market 2107.3.5 Interventional Coronary Guidewire Market 2127.3.6 Coronary Embolic Protection Device Market 2157.3.7 Coronary Atherectomy Device Market 2187.3.8 Introducer Sheath Market 2217.3.9 Coronary Vascular Closure Device Market 2247.3.10 Diagnostic Coronary Catheter & Guidewire Market 2267.3.10.1.1 Diagnostic Coronary Catheter Market 2297.3.10.1.2 Diagnostic Coronary Guidewire Market 2307.3.10.1.3 Fractional Flow Reserve Guidewire Market 2317.3.11 Coronary Intravascular Ultrasound Catheter Market 2327.3.12 Coronary Optical Coherence Tomography Catheter Market 235

LATIN AMERICA MARKET

8.1 INTRODUCTION 2378.1.1 Population at Risk 2378.1.2 Countries Included 2388.2 MARKET OVERVIEW 2398.3 MARKET ANALYSIS AND FORECAST 2458.3.1 Coronary Stent Market 2458.3.1.1 Total Coronary Stent Market 2488.3.1.1.1 Bare-Metal Stent Market 2498.3.1.1.2 Drug-Eluting Stent Market 2508.3.2 Coronary Balloon Catheter Market 2518.3.2.1 Total Coronary Balloon Catheter Market 2538.3.2.1.1 PTCA Balloon Catheter Market 2548.3.2.1.2 Drug-Eluting Balloon Catheter Market 2558.3.2.1.3 Specialty Balloon Catheter Market 2568.3.3 Balloon-Inflation Device Market 2578.3.4 Interventional Coronary Catheter Market 2608.3.5 Interventional Coronary Guidewire Market 2628.3.6 Coronary Embolic Protection Device Market 2658.3.7 Coronary Atherectomy Device Market 2688.3.8 Introducer Sheath Market 2718.3.9 Coronary Vascular Closure Device Market 2748.3.10 Diagnostic Coronary Catheter & Guidewire Market 2778.3.10.1.1 Diagnostic Coronary Catheter Market 2808.3.10.1.2 Diagnostic Coronary Guidewire Market 2818.3.10.1.3 Fractional Flow Reserve Guidewire Market 2828.3.11 Coronary Intravascular Ultrasound Catheter Market 2838.3.12 Coronary Optical Coherence Tomography Catheter Market 286 For a Full Table of Contents, please contact iData.
The Interventional Cardiology Market Report Suite| Global | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:
  • Aachen Scientific
  • Abbott
  • ACIST
  • Acrostak
  • Advanced Vascular Dynamics
  • AngioDynamics
  • Argon Medical
  • Asahi Intecc
  • B. Braun
  • Baylis Medical
  • Becton Dickinson
  • Biolife
  • Biosensors International
  • Biotronik
  • Boston Scientific
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Cardiva Medical
  • CeloNova
  • Clearstream Technologies
  • Control Medical Technology
  • Cook Medical
  • DISA Medinotec
  • Galt Medical
  • Getinge
  • ICU Medical
  • Infraredx
  • InnoTherapy
  • Medtronic
  • Merit Medical
  • Morris Innovative
  • Opsens Medical
  • Oscor
  • PediaVascular
  • Philips
  • Reflow Medical
  • Rontis
  • Semier Technologies
  • Teleflex
  • Terumo
  • Tricol Biomedical
  • Tryton Medical
  • TZ Medical
  • US Endovascular
  • Vivasure
  • Z-Medica
One of the most accurate methods of market research in the medical device industry is to analyze the procedure volumes and trends. Through this study on the global interventional cardiology devices, iData Research has performed an analysis on the following procedure segments in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range.

Global Interventional Cardiology Procedure Volumes

Global Interventional Cardiology Procedure Volume Analysis

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology